Nearly all individuals with intellectual and developmental disabilities experienced improvement in tardive dyskinesia severity after starting INGREZZA, and of those, 89% experienced improvement...

Data being presented, including six oral presentations, reinforce AbbVie's leadership and commitment to ongoing research to improve outcomes for people living with blood cancers NORTH CHICAGO,...

Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, has been selected to present Phase II updated results for BW-20805 at the...

-- FDA-cleared device minimizes CT/MRI artifacts, remains radiopaque under fluoroscopy -- BOULDER, Colo., June 8, 2026 /PRNewswire/ -- Embolization, Inc., will present its novel embolization...

This is a report from China.org.cn Video Link: https://youtu.be/9NLo7nKtGo8 The China International Supply Chain Expo, or CISCE, showcases not only finished products but also the networks of...